Harnessing the Benefits of Endogenous Hydrogen Sulfide to Reduce Cardiovascular Disease

Cardiovascular disease is the leading cause of death in the U.S. While various studies have shown the beneficial impact of exogenous hydrogen sulfide (H(2)S)-releasing drugs, few have demonstrated the influence of endogenous H(2)S production. Modulating the predominant enzymatic sources of H(2)S—cys...

Descripción completa

Detalles Bibliográficos
Autores principales: Casin, Kevin M., Calvert, John W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000539/
https://www.ncbi.nlm.nih.gov/pubmed/33806545
http://dx.doi.org/10.3390/antiox10030383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000539/
https://www.ncbi.nlm.nih.gov/pubmed/33806545
http://dx.doi.org/10.3390/antiox10030383

Ejemplares similares